The Patent Finder

Message Pharmaceuticals, Inc.

Also on record
Records under this name other than patents Message Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Message Pharmaceuticals, Inc.

PatentTitleStatus Expires Confidence
US 7,153,882Agents Useful for Reducing Amyloid Precursor Protein and Treating Demantia and Methods of Use Thereof
Formerly held
Term ended
Term ended Dec 23, 2022 · High confidence
Term endedTerm ended Dec 23, 2022High confidence
US 6,465,176Method for identifying compounds RNA/RNA binding protein interactions
Lapsed on the fee record
Ended Oct 15, 2014 · From the USPTO record
Lapsed on the fee recordEnded Oct 15, 2014From the USPTO record
US 6,448,007Functional genomic screen for post-transcriptional 5′ and 3′ regulatory elements
Lapsed on the fee record
Ended Sep 10, 2014 · From the USPTO record
Lapsed on the fee recordEnded Sep 10, 2014From the USPTO record
US 7,078,171Methods for identifying novel nucleic acid regulatory elements and compounds that affect the regulation
Lapsed on the fee record
Ended Jul 18, 2014 · From the USPTO record
Lapsed on the fee recordEnded Jul 18, 2014From the USPTO record
US 7,037,660Methods for detecting and quantifying binding and inhibition of binding of species to nucleic acids
Lapsed on the fee record
Ended May 2, 2014 · From the USPTO record
Lapsed on the fee recordEnded May 2, 2014From the USPTO record
US 6,107,029Universal method for detecting interactions between RNA molecules and RNA binding proteins
Lapsed on the fee record
Ended Aug 22, 2012 · From the USPTO record
Lapsed on the fee recordEnded Aug 22, 2012From the USPTO record
US 7,001,924Inhibitors of RNase P proteins as antibacterial compounds
Lapsed on the fee record
Ended Feb 21, 2010 · From the USPTO record
Lapsed on the fee recordEnded Feb 21, 2010From the USPTO record
US 6,936,432Novel Bacterial Rnase P Proteins and Their Use in Identifying Antibacterial Compounds
Lapsed on the fee record
Ended Aug 30, 2009 · Medium confidence
Lapsed on the fee recordEnded Aug 30, 2009Medium confidence
US 6,872,850Small molecule inhibitors of secretion of proteins encoded by ARE-mRNAs
Lapsed on the fee record
Ended Mar 29, 2009 · From the USPTO record
Lapsed on the fee recordEnded Mar 29, 2009From the USPTO record
US 6,630,589Identification of compounds for the treatment or prevention of proliferative diseases
Lapsed on the fee record
Ended Oct 7, 2007 · From the USPTO record
Lapsed on the fee recordEnded Oct 7, 2007From the USPTO record
10 of 12 patents shown.
Pro members see all 12.
Pro members: see all 12 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited